News

OKTA (OKTA) Surged as its Financial Performance Exceeded Market Expectations
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” first quarter 2025 investor letter.
Strong Business Performance Lifted RB Global (RBA) in Q1
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” first quarter 2025 investor letter.
Meridian Growth Fund’s Q1 2025 Investor Letter
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” first quarter 2025 investor letter.
Here’s Why Bio-Rad Laboratories (BIO) Traded Lower in Q1
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor ...
What Makes Permian Resources Corporation (PR) an Investment Bet?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor ...
Polaris (PII) Declined on Weak Demand
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor ...
Does Genpact (G) Have a Long Runway for Growth?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor ...
Understanding the Key Benefits and Limitations of Demo Accounts in Trading
In the ever-evolving world of trading, a demo or paper trading account has become an essential tool that gives users the ...
Citizens JMP Raises Pegasystems (PEGA) Price Target, Maintains Outperform Rating
On June 3, Citizens JMP raised its price target on Pegasystems Inc. (NASDAQ: PEGA) to $125 from $110, maintaining an Outperform rating after attending the company’s annual PegaWorld 2025 user ...
Citi Keeps Hims & Hers (HIMS) Price Target, Maintains Sell Rating
Citi is holding firm on its Sell rating for Hims & Hers Health, Inc. (NYSE: HIMS ), according to a report released on June 3, ...
Piper Sandler Trims UnitedHealth (UNH) Price Target, Maintains Overweight Rating
Piper Sandler sharply lowered its price target on UnitedHealth Group Incorporated (NYSE:UNH) to $353 from $552, while maintaining an Overweight rating.